Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up malaria rechallenge study after single immunization with genetically attenuated Plasmodium falciparum Δmei2 sporozoites
NL-OMON60459Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of genetically attenuated Plasmodium falciparum Δmei2 sporozoites in Malaria (2 arms), sponsored by Leiden University Medical Center. Started Oct 2024; status: completed.
02
Drugs
genetically attenuated Plasmodium falciparum Δmei2 sporozoites
03
Conditions
Malaria
Beyond the preview
Go deeper on NL-OMON60459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60459.